Schorge JO - Search Results

1

Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer.

Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM 2nd, Horowitz NS, del Carmen MG, Schorge JO. Rauh-Hain JA, et al. Among authors: schorge jo. Ann Surg Oncol. 2012 Mar;19(3):959-65. doi: 10.1245/s10434-011-2100-x. Epub 2011 Oct 13. Ann Surg Oncol. 2012. PMID: 21994038

2

The effect of postsurgical therapy on stage III endometrial carcinoma.

Schorge JO, Molpus KL, Goodman A, Nikrui N, Fuller AF Jr. Schorge JO, et al. Gynecol Oncol. 1996 Oct;63(1):34-9. doi: 10.1006/gyno.1996.0274. Gynecol Oncol. 1996. PMID: 8898165

3

Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy.

Schorge JO, Molpus KL, Koelliker D, Nikrui N, Goodman A, Fuller AF Jr. Schorge JO, et al. Gynecol Oncol. 1997 Jul;66(1):31-5. doi: 10.1006/gyno.1997.4691. Gynecol Oncol. 1997. PMID: 9234917 Clinical Trial.

4

Stage IA1 cervical adenocarcinoma: definition and treatment.

Schorge JO, Lee KR, Flynn CE, Goodman A, Sheets EE. Schorge JO, et al. Obstet Gynecol. 1999 Feb;93(2):219-22. doi: 10.1016/s0029-7844(98)00371-8. Obstet Gynecol. 1999. PMID: 9932559

5

Early cervical adenocarcinoma: selection criteria for radical surgery.

Schorge JO, Lee KR, Lee SJ, Flynn CE, Goodman A, Sheets EE. Schorge JO, et al. Obstet Gynecol. 1999 Sep;94(3):386-90. doi: 10.1016/s0029-7844(99)00312-9. Obstet Gynecol. 1999. PMID: 10472864

6

Clinically significant venous thromboembolism after gynecologic surgery.

Schorge JO, Goldhaber SZ, Duska LR, Goodman A, Feldman S. Schorge JO, et al. J Reprod Med. 1999 Aug;44(8):669-73. J Reprod Med. 1999. PMID: 10483535

7

Genetic alterations of the WT1 gene in papillary serous carcinoma of the peritoneum.

Schorge JO, Miller YB, Qi LJ, Muto MG, Welch WR, Berkowitz RS, Mok SC. Schorge JO, et al. Gynecol Oncol. 2000 Mar;76(3):369-72. doi: 10.1006/gyno.1999.5711. Gynecol Oncol. 2000. PMID: 10684712

8

Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix.

Boruta DM 2nd, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE. Boruta DM 2nd, et al. Among authors: schorge jo. Gynecol Oncol. 2001 Apr;81(1):82-7. doi: 10.1006/gyno.2000.6118. Gynecol Oncol. 2001. PMID: 11277655

9

Fertility-sparing surgery for ovarian low malignant potential tumors.

Rao GG, Skinner EN, Gehrig PA, Duska LR, Miller DS, Schorge JO. Rao GG, et al. Among authors: schorge jo. Gynecol Oncol. 2005 Aug;98(2):263-6. doi: 10.1016/j.ygyno.2005.04.025. Gynecol Oncol. 2005. PMID: 15964063

10

Implications of EGFR inhibition in ovarian cancer cell proliferation.

Bull Phelps SL, Schorge JO, Peyton MJ, Shigematsu H, Xiang LL, Miller DS, Lea JS. Bull Phelps SL, et al. Among authors: schorge jo. Gynecol Oncol. 2008 Jun;109(3):411-7. doi: 10.1016/j.ygyno.2008.02.030. Gynecol Oncol. 2008. PMID: 18423824

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183 results

Search Page

Filters